Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ITPRIPL1 Inhibitors

ITPRIPL1 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the ITPRIPL1 protein. ITPRIPL1, short for inositol 1,4,5-trisphosphate receptor interacting protein-like 1, is involved in calcium signaling within cells. This protein interacts with the inositol 1,4,5-trisphosphate receptor (IP3R), which plays a crucial role in the regulation of intracellular calcium release from the endoplasmic reticulum. By binding to ITPRIPL1, these inhibitors disrupt the normal interaction between ITPRIPL1 and IP3R, thereby modulating the dynamics of calcium signaling pathways. This modulation can influence various cellular processes dependent on calcium homeostasis, such as cell proliferation, differentiation, and apoptosis.

The specificity of ITPRIPL1 inhibitors is of particular interest in biochemical studies, as they provide tools to investigate the role of calcium signaling in a variety of physiological contexts. The inhibitors can alter the calcium flux by preventing ITPRIPL1 from functioning normally, allowing researchers to explore the intricacies of calcium-dependent cellular mechanisms. This interference with calcium regulation can further affect downstream signaling cascades, influencing processes such as gene expression and enzyme activation. Overall, ITPRIPL1 inhibitors serve as valuable tools for understanding the cellular and molecular mechanisms governed by calcium dynamics, offering insights into how ITPRIPL1 functions within broader intracellular signaling networks.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

An IP3 receptor antagonist that may indirectly affect ITPRIPL1 by modulating IP3R-mediated calcium release.

Xestospongin C

88903-69-9sc-201505
50 µg
$510.00
14
(1)

A specific IP3 receptor inhibitor, potentially influencing ITPRIPL1 activity by altering IP3R-mediated signaling.

SK&F 96365

130495-35-1sc-201475
sc-201475B
sc-201475A
sc-201475C
5 mg
10 mg
25 mg
50 mg
$103.00
$158.00
$397.00
$656.00
2
(1)

An inhibitor of receptor-mediated calcium entry, potentially influencing ITPRIPL1-related signaling.

Ryanodine

15662-33-6sc-201523
sc-201523A
1 mg
5 mg
$223.00
$799.00
19
(2)

Affects calcium release from the endoplasmic reticulum and may indirectly influence ITPRIPL1 activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

An inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), indirectly affecting calcium homeostasis and potentially ITPRIPL1.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

A calcium chelator that can modulate intracellular calcium levels, potentially affecting ITPRIPL1.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor, which might indirectly affect ITPRIPL1 through modulation of downstream signaling pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor, potentially affecting signaling pathways related to ITPRIPL1.

Dantrolene

7261-97-4sc-500165
25 mg
$350.00
7
(0)

An inhibitor of ryanodine receptors, potentially affecting calcium signaling related to ITPRIPL1.